Orthopaedics

Menopausal Osteoporosis

Despite there is not drugs capable to reduce the risk of fractures of 50%-70% after 6-12 months of treatment, postmenopausal osteoporosis often remains not recognized and consequently not treated, with easily foreseeable consequences. The North American Menopause Society (NAMS), in its declarations in 2010, affirms that all women in post-menopause should be assessed for risk factors associated with osteoporosis, to recognize fracture risk factors, to eliminate possible causes for secondary osteoporosis, to modify risk factors and to choose candidates for pharmacological therapy.
Read more

 http://mn.medsurfnews.com/contents/en/6203/display/menopausa...

MedNews